Menu Close

Articles on Europe

Displaying 401 - 420 of 1284 articles

In Saint-Laurent-Nouan, in the Loir-et-Cher region, one of 19 French power plants. Ludovic Marin/AFP

Nuclear power in France: imagining the industry’s future

Nuclear energy generates 75% of France’s electricity, and ongoing troubles at the new Flamanville EPR reactor have raised crucial questions about its future in the country’s electricity mix.
A crane carrying with melting steel at the blast furnace Schwelgern 2 at ThyssenKrupp steel mill in Duisburg , Germany (December 12, 2014). Patrik Stollarz/AFP

The ‘circularity paradox’ in the European steel industry

Europe recycles 70% of its steel, but much is exported, turning what should be a circular process into a linear one. Instead, materials need to be circularity-ready the moment they’re manufactured.
Supporters of the anti-Islam party Pegida attend a rally in Copenhagen on January 19, 2015. Juliane Lydolph/AFP

Asylum seekers and immigrant threat: Is there a link?

The perception of an immigrant threat in Europe is often thought to be driven by rising numbers of asylum seekers, but research indicates that political and media discourses are often the driving factor.
A reception centre near Namur, Wallonia, one of the largest in the Belgian reception network. May 24, 2018. LUCA MANUNZA/lucalasius/instagram

How do asylum seekers view Belgium’s emergency system?

Only rarely are refugees’ and migrants’ words taken into account about the reception system in Europe. And what they tell us is frightening.
Jacques Chirac (here in 2005) was a defining figure in French politics after May 1968. World Economic Forum/Flickr

Jacques Chirac, 1932-2019: a political bulldozer

A look back at the distinguished career of the former president, an ardent defender of France’s place in the world.
The effectiveness of a drug may be evaluated based on its potential to shrink tumours – but this doesn’t necessarily equate to improved survival rates. From shutterstock.com

Do new cancer drugs work? Too often we don’t really know (and neither does your doctor)

National drug regulators use evidence from clinical trials to decide whether new cancer drugs will be approved for use. But these studies are often flawed.

Top contributors

More